We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$289M
1-Year Est. Return
30.86%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$127M
AUM Growth
-$4.96M
(-3.8%)
Cap. Flow
-$4.11M
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
77.16%
Holding
60
New
1
Increased
9
Reduced
22
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$219K |
| 2 |
Tompkins Financial
TMP
|
+$111K |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$97.7K |
| 4 |
United Parcel Service
UPS
|
+$40.7K |
| 5 |
Verizon
VZ
|
+$39.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$940K |
| 2 |
CELG
Celgene Corp
CELG
|
+$799K |
| 3 |
Johnson & Johnson
JNJ
|
+$289K |
| 4 |
T. Rowe Price
TROW
|
+$234K |
| 5 |
Pfizer
PFE
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.01% |
| 2 | Technology | 26.21% |
| 3 | Communication Services | 5.9% |
| 4 | Financials | 3.54% |
| 5 | Consumer Discretionary | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intel
INTC
$455B
| $697K | 0.55% |
22,922
+200
| +0.9% | +$6.47K |
|
27
Franklin Resources
BEN
$17.6B
| $625K | 0.49% |
12,750
| – | – |
|
28
Visa
V
$684B
| $618K | 0.49% |
9,200
-800
| -8% | -$54.2K |
|
29
Public Service Enterprise Group
PEG
$38.2B
| $598K | 0.47% |
15,222
| – | – |
|
30
IBM
IBM
$211B
| $540K | 0.42% |
3,473
| – | – |
|
31
Amgen
AMGN
$208B
| $538K | 0.42% |
3,505
-250
| -7% | -$40K |
|
32
SLB Ltd
SLB
$73.6B
| $530K | 0.42% |
6,150
| – | – |
|
|
33
Verizon
VZ
$195B
| $509K | 0.4% |
10,912
+800
| +8% | +$39.2K |
|
34
United Natural Foods
UNFI
$3.08B
| $497K | 0.39% |
7,800
| – | – |
|
35
Amazon
AMZN
$2.92T
| $486K | 0.38% |
22,400
| – | – |
|
36
Bristol-Myers Squibb
BMY
$133B
| $484K | 0.38% |
7,270
-1,100
| -13% | -$72.5K |
|
37
Eli Lilly
LLY
$1.02T
| $460K | 0.36% |
5,514
| – | – |
|
38
PepsiCo
PEP
$190B
| $422K | 0.33% |
4,525
-1,800
| -28% | -$172K |
|
39
Microchip Technology
MCHP
$40.3B
| $386K | 0.3% |
16,270
-400
| -2% | -$9.71K |
|
40
Merck
MRK
$322B
| $369K | 0.29% |
6,798
| – | – |
|
|
STJ
41
DELISTED
St Jude Medical
STJ
| $325K | 0.26% |
4,450
| – | – |
|
42
Illumina
ILMN
$31B
| $306K | 0.24% |
1,439
| – | – |
|
43
Cognizant
CTSH
$24.9B
| $299K | 0.24% |
4,900
| – | – |
|
44
AllianceBernstein
AB
$3.43B
| $297K | 0.23% |
10,060
| – | – |
|
|
BNY
45
Bank of New York Mellon
BNY
$106B
| $294K | 0.23% |
7,000
| – | – |
|
|
VAR
46
DELISTED
Varian Medical Systems, Inc.
VAR
| $291K | 0.23% |
3,934
-456
| -10% | -$35.7K |
|
47
Caterpillar
CAT
$375B
| $280K | 0.22% |
3,300
| – | – |
|
48
Home Depot
HD
$331B
| $278K | 0.22% |
2,500
| – | – |
|
|
49
Gilead Sciences
GILD
$162B
| $234K | 0.18% |
+2,000
| New | +$219K |
|
50
Boston Scientific
BSX
$69.5B
| $204K | 0.16% |
11,504
-1,932
| -14% | -$34.5K |
|
Similar funds
LWP
BWAM
WPWM
PIA
CCC
GIM
PSA
SI
Bourne Lent Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Bourne Lent Asset Management held 60 positions worth $127M, down 3.8% from $132M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Bourne Lent Asset Management withdrew a net $4.11M in Q2 2015, closing 9 positions and reducing 22 holdings. Its most notable exit was AbbVie, an estimated $940K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 55% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Bourne Lent Asset Management opened a new position in Gilead Sciences worth $234K.
- Bourne Lent Asset Management's largest Q2 2015 buy was Gilead Sciences: 2,000 shares worth $234K.
- Bourne Lent Asset Management added most to Tompkins Financial in Q2 2015, an estimated $111K increase.
- Bourne Lent Asset Management's biggest Q2 2015 reduction was Celgene Corp, cutting an estimated $799K.
- Bourne Lent Asset Management fully exited AbbVie in Q2 2015, selling an estimated $940K.
- Bourne Lent Asset Management's ten largest holdings make up 77% of its $127M portfolio in Q2 2015.
- Bourne Lent Asset Management opened 1 new position and closed 9 in Q2 2015.
- Bourne Lent Asset Management's portfolio value fell 3.8% quarter-over-quarter to $127M.
Based on Bourne Lent Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.